神经轴突蛋白-1在癫痫中的作用机制研究进展
Research Progress on the Mechanisms of Neurexin-1 in Epilepsy
DOI: 10.12677/acm.2025.15113206, PDF,    科研立项经费支持
作者: 葛 玲:济宁医学院临床医学院(附属医院),山东 济宁;李秋波, 魏善英*:济宁医学院附属医院儿科,山东 济宁
关键词: NRXN1癫痫突触可塑性兴奋/抑制平衡发病机制NRXN1 Epilepsy Synaptic Plasticity Excitatory/Inhibitory Balance Pathogenesis
摘要: 癫痫,特别是药物难治性癫痫,是神经系统的重大挑战,其发病机制复杂,仍有待深入阐明。近年来,遗传因素在癫痫中的作用日益受到重视。神经轴突蛋白-1 (NRXN1)基因编码一种关键的突触前细胞粘附分子,通过与其突触后配体(如神经配蛋白,Neuroligin)结合,在突触的形成、维持和功能调控中扮演核心角色。NRXN1的遗传变异已被证实与自闭症谱系障碍、精神分裂症、智力障碍等多种神经精神疾病密切相关,而这些疾病常与癫痫共病,提示NRXN1可能是连接这些疾病的分子桥梁之一。本文旨在综述NRXN1的生物学功能、其在神经系统疾病中的作用,并重点探讨NRXN1表达异常或功能缺失通过影响突触可塑性、扰乱神经环路兴奋/抑制(E/I)平衡,进而参与癫痫发病机制的最新研究进展。对NRXN1的深入研究,有望为揭示癫痫,尤其是难治性癫痫的病因提供新视角,并为开发新的治疗策略提供潜在靶点。
Abstract: Epilepsy, particularly drug-resistant epilepsy, poses a significant challenge to the nervous system. Its pathogenesis is complex and remains to be fully elucidated. In recent years, genetic factors have received increasing attention in epilepsy research. The Neurexin-1 (NRXN1) gene encodes a critical presynaptic cell adhesion molecule that interacts with its postsynaptic ligands, such as Neuroligin, playing a central role in synapse formation, maintenance, and functional regulation. Genetic variations in NRXN1 have been closely associated with various neuropsychiatric disorders, including autism spectrum disorder, schizophrenia, and intellectual disability. These disorders often co-occur with epilepsy, suggesting that NRXN1 may serve as a molecular bridge connecting these conditions. This review aims to summarize the biological functions of NRXN1, its role in nervous system diseases, and, in particular, to discuss the latest research progress on how abnormal expression or functional loss of NRXN1 may contribute to epilepsy pathogenesis by affecting synaptic plasticity and disrupting the excitatory/inhibitory (E/I) balance of neural circuits. In-depth study of NRXN1 is expected to provide new insights into the etiology of epilepsy, especially drug-resistant epilepsy, and offer potential targets for developing novel therapeutic strategies.
文章引用:葛玲, 李秋波, 魏善英. 神经轴突蛋白-1在癫痫中的作用机制研究进展[J]. 临床医学进展, 2025, 15(11): 1169-1174. https://doi.org/10.12677/acm.2025.15113206

参考文献

[1] World Health Organization (2019) Epilepsy: A Public Health Imperative. World Health Organization.
[2] Kwan, P., Arzimanoglou, A., Berg, A.T., Brodie, M.J., Allen Hauser, W., Mathern, G., et al. (2010) Definition of Drug Resistant Epilepsy: Consensus Proposal by the Ad Hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 51, 1069-1077. [Google Scholar] [CrossRef] [PubMed]
[3] Ryvlin, P., Nashef, L., Lhatoo, S.D., Bateman, L.M., Bird, J., Bleasel, A., et al. (2013) Incidence and Mechanisms of Cardiorespiratory Arrests in Epilepsy Monitoring Units (MORTEMUS): A Retrospective Study. The Lancet Neurology, 12, 966-977. [Google Scholar] [CrossRef] [PubMed]
[4] Myers, C.T. and Mefford, H.C. (2015) Advancing Epilepsy Genetics in the Genomic Era. Genome Medicine, 7, Article No. 91. [Google Scholar] [CrossRef] [PubMed]
[5] 王学峰, 陈阳美. 癫痫发病机制研究进展[J]. 中华神经科杂志, 2018, 51(4): 247-251.
[6] Südhof, T.C. (2008) Neuroligins and Neurexins Link Synaptic Function to Cognitive Disease. Nature, 455, 903-911. [Google Scholar] [CrossRef] [PubMed]
[7] 张永荣, 陈旭, 王艺. NRXN1基因缺失与抽动秽语综合征关联研究[J]. 中华医学遗传学杂志, 2020, 37(5): 521-524.
[8] Ushkaryov, Y.A., Petrenko, A.G., Geppert, M. and Südhof, T.C. (1992) Neurexins: Synaptic Cell Surface Proteins Related to the α-Latrotoxin Receptor and Laminin. Science, 257, 50-56. [Google Scholar] [CrossRef] [PubMed]
[9] Treutlein, B., Gokce, O., Quake, S.R. and Südhof, T.C. (2014) Cartography of Neurexin Alternative Splicing Mapped by Single-Molecule Long-Read mRNA Sequencing. Proceedings of the National Academy of Sciences of the United States of America, 111, E1291-E1299. [Google Scholar] [CrossRef] [PubMed]
[10] Tabuchi, K. and Südhof, T.C. (2002) Structure and Evolution of Neurexin Genes: Insight into the Mechanism of Alternative Splicing. Genomics, 79, 849-859. [Google Scholar] [CrossRef] [PubMed]
[11] Missler, M., Sudhof, T.C. and Biederer, T. (2012) Synaptic Cell Adhesion. Cold Spring Harbor Perspectives in Biology, 4, a005694. [Google Scholar] [CrossRef] [PubMed]
[12] Ichtchenko, K., Hata, Y., Nguyen, T., Ullrich, B., Missler, M., Moomaw, C., et al. (1995) Neuroligin 1: A Splice Site-Specific Ligand for β-Neurexins. Cell, 81, 435-443. [Google Scholar] [CrossRef] [PubMed]
[13] de Wit, J., Sylwestrak, E., O'Sullivan, M.L., Otto, S., Tiglio, K., Savas, J.N., et al. (2009) LRRTM2 Interacts with Neurexin1 and Regulates Excitatory Synapse Formation. Neuron, 64, 799-806. [Google Scholar] [CrossRef] [PubMed]
[14] Uemura, T., Lee, S., Yasumura, M., Takeuchi, T., Yoshida, T., Ra, M., et al. (2010) Trans-Synaptic Interaction of Glurδ2 and Neurexin through Cbln1 Mediates Synapse Formation in the Cerebellum. Cell, 141, 1068-1079. [Google Scholar] [CrossRef] [PubMed]
[15] Marshall, C.R., Noor, A., Vincent, J.B., Lionel, A.C., Feuk, L., Skaug, J., et al. (2008) Structural Variation of Chromosomes in Autism Spectrum Disorder. The American Journal of Human Genetics, 82, 477-488. [Google Scholar] [CrossRef] [PubMed]
[16] Rujescu, D., Ingason, A., Cichon, S., Pietiläinen, O.P.H., Barnes, M.R., Toulopoulou, T., et al. (2008) Disruption of the Neurexin 1 Gene Is Associated with Schizophrenia. Human Molecular Genetics, 18, 988-996. [Google Scholar] [CrossRef] [PubMed]
[17] Ching, M.S.L., Shen, Y., Tan, W., Jeste, S.S., Morrow, E.M., Chen, X., et al. (2010) Deletions of NRXN1 (Neurexin‐1) Predispose to a Wide Spectrum of Developmental Disorders. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153, 937-947. [Google Scholar] [CrossRef] [PubMed]
[18] 曲书慧, 刘文淼, 沈露. Tourette综合征患儿轴突蛋白1基因突变研究[J]. 中国神经精神疾病杂志, 2023, 49(10): 584-590.
[19] Saito, S., Kobayashi, S., Yamaguchi, M., et al. (2021) Neurexin-1 and Its Ligand Neuroligin-1 Are Novel Components of the Neuronal Amyloid-β Precursor Protein (APP) Metabolism Pathway. Journal of Biological Chemistry, 296, Article ID: 100174.
[20] Zweier, C., de Jong, E.K., Zweier, M., Orrico, A., Ousager, L.B., Collins, A.L., et al. (2009) CNTNAP2 and NRXN1 Are Mutated in Autosomal-Recessive Pitt-Hopkins-Like Mental Retardation and Determine the Level of a Common Synaptic Protein in Drosophila. The American Journal of Human Genetics, 85, 655-666. [Google Scholar] [CrossRef] [PubMed]
[21] Møller, R.S., Weber, Y.G., Klitten, L.L., Trucks, H., Muhle, H., Kunz, W.S., et al. (2013) Exon‐Disrupting Deletions of NRXN1 in Idiopathic Generalized Epilepsy. Epilepsia, 54, 256-264. [Google Scholar] [CrossRef] [PubMed]
[22] 王琳, 姜玉武, 杨艳玲. 儿童癫痫性脑病基因诊断研究进展[J]. 中华儿科杂志, 2019, 57(1): 68-72.
[23] Fassio, A., Patry, L., Congia, S., Onofri, F., Piton, A., Gauthier, J., et al. (2011) SYN1 Loss-Of-Function Mutations in Autism and Partial Epilepsy Cause Impaired Synaptic Function. Human Molecular Genetics, 20, 2297-2307. [Google Scholar] [CrossRef] [PubMed]
[24] Etherton, M.R., Blaiss, C.A., Powell, C.M. and Südhof, T.C. (2009) Mouse Neurexin-1α Deletion Causes Correlated Electrophysiological and Behavioral Changes Consistent with Cognitive Impairments. Proceedings of the National Academy of Sciences of the United States of America, 106, 17998-18003. [Google Scholar] [CrossRef] [PubMed]
[25] Grayton, H.M., Missler, M., Collier, D.A. and Fernandes, C. (2013) Altered Social Behaviours in Neurexin 1α Knockout Mice Resemble Core Symptoms in Neurodevelopmental Disorders. PLOS ONE, 8, e67114. [Google Scholar] [CrossRef] [PubMed]
[26] Aoto, J., Martinelli, D.C., Malenka, R.C., Tabuchi, K. and Südhof, T.C. (2013) Presynaptic Neurexin-3 Alternative Splicing Trans-Synaptically Controls Postsynaptic AMPA Receptor Trafficking. Cell, 154, 75-88. [Google Scholar] [CrossRef] [PubMed]
[27] Sudhof, T.C. (2018) Towards an Understanding of Synapse Formation and Plasticity. Cell, 175, 10-13.